Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
Clinical trial NCT02377895 · COMPLETED
Trial details
- NCT number
- NCT02377895
- Sponsor
- 3E Therapeutics Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-07-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.